Document:

<PAGE>

                                                                    EXHIBIT 10.2

                                                                  EXECUTION COPY

                         REGISTRATION RIGHTS AGREEMENT

     This REGISTRATION RIGHTS AGREEMENT is entered into as of October 1, 2000
among EDAP TMS S.A., a French corporation ("EDAP"), Technomed Medical Systems
S.A., a French corporation ("French Subsidiary"), EDAP Technomed Inc., a
Delaware corporation ("U.S. Subsidiary") and Urologix, Inc., a Minnesota
corporation ("Urologix").

                                    RECITALS

     WHEREAS, the Company and the Holders have entered into an Asset Purchase
Agreement dated as of the date hereof under which the Company will issue to
Holders collectively a total of 1,365,000 shares of Urologix Common Stock and a
warrant ("Warrant") to purchase 327,466 shares of Urologix Common Stock at a
price set forth in the Asset Purchase Agreement.

     WHEREAS, the parties desire to set forth certain registration rights and
other obligations applicable to the Registrable Shares (as defined below) held
by the Holders.

     NOW, THEREFORE, in consideration of the premises and the mutual covenants
herein contained and for other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, and upon the terms and subject to
the conditions hereof, the parties hereby agree as follows:

     1.1  Certain Definitions.  As used in this Agreement, the following terms
          -------------------
shall have the meanings set forth below:

          (a)  "Closing" shall mean the date of the closing of the Asset
Purchase Agreement.

          (b)  "Commission" shall mean the United States Securities and Exchange
Commission or any other federal agency at the time administering the Securities
Act.

          (c)  "Company" shall mean Urologix.

          (d)  "Exchange Act" shall mean the Securities Exchange Act of 1934, as
amended, or any similar successor federal statute and the rules and regulations
thereunder, all as the same shall be in effect from time to time.

          (e)  "Holder" shall mean any stockholder who holds Registrable Shares
and any holder of Registrable Shares to whom the registration rights conferred
by this Agreement have been transferred in compliance with Section 1.10 hereof.

          (f)  "Indemnified Parties" shall mean each Holder, each of their
respective

                                       1
<PAGE>

officers, directors and employees, and each person controlling such Holder
within the meaning of Section 15 of the Securities Act.

          (g)  "Other Stockholders" shall mean persons other than Holders who,
by virtue of agreements with the Company, are entitled to include their
securities in certain registrations hereunder.

          (h)  "Registrable Shares" shall mean (i) shares of Common Stock issued
to Holders as a result of the Asset Purchase Agreement including shares issuable
upon exercise of the Warrant; and (ii) any Common Stock issued as a dividend or
other distribution with respect to or in exchange for or in replacement of the
shares referenced in (i) above, provided, however, that Registrable Shares shall
not include any shares of Common Stock that have previously been registered and
that have been sold to the public.

          (i)  The terms "register," "registered" and "registration" shall refer
to a registration effected by preparing and filing a registration statement in
compliance with the Securities Act and applicable rules and regulations
thereunder, and the declaration or ordering of the effectiveness of such
registration statement.

          (j)  "Registration Expenses" shall mean all expenses incurred in
effecting any registration pursuant to this Agreement, including, without
limitation, all registration, qualification, and filing fees, printing expenses,
fees and disbursements of counsel and accountants for the Company, fees and
disbursements of counsel for the Holders (up to $10,000 in connection with any
one registration), blue sky fees and expenses and related Company legal fees and
disbursements, and expenses of any regular or special audits incident to or
required by any such registration, but shall not include Selling Expenses (but
excluding the compensation of regular employees of the Company, which shall be
paid in any event by the Company).

          (k)  "Rule 144" shall mean Rule 144 as promulgated by the Commission
under the Securities Act, as such Rule may be amended from time to time, or any
similar successor rule that may be promulgated by the Commission.

          (l)  "Rule 144A" shall mean Rule 144A as promulgated by the Commission
under the Securities Act, as such Rule may be amended from time to time, or any
similar successor rule that may be promulgated by the Commission.

          (m)  "Rule 145" shall mean Rule 145 as promulgated by the Commission
under the Securities Act, as such Rule may be amended from time to time, or any
similar successor rule that may be promulgated by the Commission.

          (n)  "Securities Act" shall mean the Securities Act of 1933, as
amended, or any similar successor federal statute and the rules and regulations
thereunder, all as the same shall be in effect from time to time.

                                       2
<PAGE>

          (o)  "Selling Expenses" shall mean all underwriting discounts and
selling commissions applicable to the sale of Registrable Shares.

     1.2  Requested Registration.
          ----------------------

          (a)  Request for Registration. If the Company shall receive from
Holders of the Registrable Shares (the "Initiating Holders"), at any time after
twelve months following the Closing, a written request that the Company effect
any registration of Registrable Shares consisting of at least thirty-three
percent of the Registrable Shares, or if the Holders continue to own less than
thirty-three percent of the Registrable Shares, then all remaining Registrable
Shares, the Company will:

               (i)  promptly give written notice of the proposed registration to
     all Holders of Registrable Shares; and

               (ii) as soon as practicable, use its best efforts to effect such
     registration (including, without limitation, filing post-effective
     amendments, appropriate qualifications under applicable blue sky or other
     state securities laws, and appropriate compliance with the Securities Act)
     as would permit or facilitate the sale and distribution of all or such
     portion of such Registrable Shares as are specified in such request,
     together with all or such portion of the Registrable Shares of any Holder
     or Holders joining in such request as are specified in a written request
     received by the Company within twenty (20) days after such written notice
     from the Company is effective. Subject to the terms and conditions hereof,
     each request for registration by the Holders of the Registrable Shares
     shall register the offer and sale of Registrable Shares for all cash
     consideration, and a registration statement in connection therewith shall
     permit the disposition of such Registrable Shares in accordance with the
     intended method of methods of disposition specified in such Holders'
     request for registration.

          The Company shall not be obligated to effect, or to take any action to
effect, any such registration pursuant to this Section 1.2:

               (A)  In any particular jurisdiction in which the Company would be
     required to execute a general consent to service of process in effecting
     such registration, qualification or compliance, unless the Company is
     already subject to service in such jurisdiction and except as may be
     required by the Securities Act;

               (B)  After the Company has initiated four such registrations
     pursuant to this Section 1.2(a) that have been declared or ordered
     effective and pursuant to which securities have been sold by the Holders;

               (C)  Within twelve (12) months of the effective date of a
     previous registration statement filed pursuant to this Section 1.2; or

                                       3
<PAGE>

               (D)  If all the Registrable Shares proposed to be included could
     be sold under Rule 144(k) and the Company shall have caused to be provided
     to the Holders thereof an opinion of the principal counsel of the Company
     that such securities are distributable pursuant to Rule 144(k).

          (b)  Subject to the foregoing clauses (A), (B), (C) and (D) the
Company shall file a registration statement covering the Registrable Shares so
requested to be registered as soon as practicable after receipt of the request
or requests of the Initiating Holders; but in no event later than ninety (90)
days from the date of receipt of such request, and use its best efforts to cause
such registration statement to become effective; provided, however, that if (i)
in the good faith judgment of the Board of Directors of the Company, such
registration would require disclosure of material nonpublic information or
adversely interfere with a financing then underway and the Board of Directors of
the Company concludes, as a result, that it is essential to defer the filing of
such registration statement at such time, and (ii) the Company shall furnish to
such Holders a certificate signed by the President of the Company stating that
in the good faith judgment of the Board of Directors of the Company, it would
require disclosure of material nonpublic information or adversely interfere with
a financing then underway for such registration statement to be filed in the
near future and that it is, therefore, essential to defer the filing of such
registration statement, then the Company shall have the right to defer such
filing for the period during which such disclosure would be seriously
detrimental, provided that the Company may not defer the filing for a period of
more than ninety (90) days after receipt of the request of the Initiating
Holders, and, provided further, that the Company shall not defer its obligation
in this manner more than once in any twelve (12) month period.

               The registration statement filed pursuant to the request of the
Initiating Holders may include other securities of the Company with respect to
which registration rights have been granted and securities of the Company being
sold for the account of the Company.

               (c)  Underwriting. The right of any Holder to registration
pursuant to Section 1.2 shall be conditioned upon such Holder's participation in
the underwriting, if any, arranged by the Initiating Holders. A Holder may elect
to include in such underwriting all or a part of the Registrable Shares he
holds.

               (d)  Procedures.  If the Company shall request inclusion in any
registration pursuant to Section 1.2 of securities being sold for its own
account, or if other persons shall request inclusion in any registration
pursuant to Section 1.2, the Initiating Holders shall, on behalf of all Holders,
offer to include such securities in the underwriting, if any, and may condition
such offer on their acceptance of the further applicable provisions of this
agreement (including Section 1.11). The Company shall (together with all Holders
and other persons proposing to distribute their securities through such
underwriting) enter into an underwriting agreement in customary form containing
such representations and warranties by the Company as are generally prevailing
in agreements of this type, with the representative of the underwriter or
underwriters selected for such underwriting by the Company, which underwriters
are reasonably acceptable to the majority in interest of the Initiating Holders.
In any such case, the Company

                                       4
<PAGE>

shall allow the Holders of Registrable Shares and their counsel to participate
in the negotiation of such underwriting agreement, and approve its terms, such
approval not to be unreasonably withheld. Any such Holder of Registrable Shares
shall not be required to make any representations or warranties to or agreements
with the Company other than representations, warranties or agreements regarding
such Holder, such Holder's Registrable Shares and such Holder's intended method
of distribution and any other representation required by law or as reasonably
requested by the underwriters. No Person may participate in any registration
hereunder which is underwritten unless such Person (a) agrees to sell its
securities on the basis provided in such underwriting agreements; and (b)
completes and executes all questionnaires, powers of attorney (which may contain
customary terms regarding the minimum price of the Registrable Shares to be sold
in the subject offering), custody agreements, indemnities and other documents
reasonably required under the terms of such underwriting agreements. Notwith-
standing any other provision of this Section 1.2, if the representative of the
underwriters advises the Holders in writing that marketing factors require a
limitation on the number of shares to be underwritten, the number of shares to
be included in the underwriting or registration shall be allocated as set forth
in Section 1.12 hereof. Subject to the above, if a person who has requested
inclusion in such registration as provided above does not agree to the terms of
any such underwriting, such person shall be excluded therefrom by written notice
from the Company, the underwriter or the Initiating Holders. The securities so
excluded shall also be withdrawn from registration. If shares are so withdrawn
from the registration and if the number of shares to be included in such
registration was previously reduced as a result of marketing factors pursuant to
this Section 1.2(d), then the Company shall offer to all holders who have
retained rights to include securities in the registration the right to include
additional securities in the registration in an aggregate amount equal to the
number of shares so withdrawn, with such shares to be allocated among such
Holders requesting additional inclusion in accordance with Section 1.12.

     1.3  Company Registration.
          --------------------

          (a)  If, at any time beginning one year from the date of Closing, the
Company shall determine to register any of its securities either for its own
account or the account of a security holder or holders exercising their
respective demand registration rights (other than pursuant to Section 1.2),
other than (i) a registration on Form S-8 relating solely to employee benefit
plans, (ii) a registration on Form S-4 relating solely to a Rule 145
transaction, (iii) a registration contemplated by Section 1.16 or (iv) a
registration on any registration form that does not permit secondary sales, the
Company will:

               (i)  promptly give to each Holder written notice thereof; and

               (ii) use its best efforts to include in such registration (and
     any related qualification under blue sky laws or other compliance), except
     as set forth in Section 1.3(b) below, and in any underwriting involved
     therein, all the Registrable Shares specified in a written request or
     requests, made by any Holder within twenty (20) days after the written
     notice from the Company described in clause (i) above is given. Such
     written request may specify all or a part of a Holder's Registrable Shares.

                                       5
<PAGE>

          (b)  Underwriting. If the registration of which the Company gives
notice is for a registered public offering involving an underwriting, the
Company shall so advise the Holders as a part of the written notice given
pursuant to Section 1.3(a)(i). In such event, the right of any Holder to
registration pursuant to this Section 1.3 shall be conditioned upon such
Holder's participation in such underwriting and the inclusion of such Holder's
Registrable Shares in the underwriting to the extent provided herein. All
Holders proposing to distribute their securities through such underwriting shall
(together with the Company and the other holders of securities of the Company
with registration rights to participate therein distributing their securities
through such underwriting) enter into an underwriting agreement in customary
form with the representative of the underwriter or underwriters selected by the
Company.

     Notwithstanding any other provision of this Section 1.3, if the
representative of the underwriters advises the Company in writing that marketing
factors require a limitation on the number of shares to be underwritten, the
Company may limit, to the extent so advised by the underwriters, the amount of
securities (including Registrable Shares) to be included in the registration by
the Company's stockholders (including the Holders), or may exclude, to the
extent so advised by the underwriters, such securities entirely from such
registration. Subject to the above, the Company shall so advise all holders of
securities requesting registration, and the number of shares of securities that
are entitled to be included in the registration and underwriting shall be
allocated first to the Company for securities being sold for its own account and
thereafter as set forth in Section 1.12.  Subject to the terms of this
Agreement, if any person does not agree to the terms of any such underwriting,
he shall be excluded therefrom by written notice from the Company or the
underwriter.  Any Registrable Shares or other securities excluded or withdrawn
from such underwriting shall be withdrawn from such registration.

     If shares are so withdrawn from the registration or if the number of shares
of Registrable Shares to be included in such registration was previously reduced
as a result of marketing factors, the Company shall then offer to all persons
who have retained the right to include securities in the registration the right
to include additional securities in the registration in an aggregate amount
equal to the number of shares so withdrawn, with such shares to be allocated
among the persons requesting additional inclusion in accordance with Section
1.12 hereof.

     1.4  Expenses of Registration.  All Registration Expenses incurred in
          ------------------------
connection with any registration, qualification or compliance pursuant to the
registrations pursuant to Section 1.2 hereof or, shall be borne equally by the
Company and the Holders.  All Registration Expenses incurred in connection with
any registration, qualification or compliance, arising out of a registration
pursuant to Section 1.3, shall be borne by the Company and the Holders on a pro
rata basis based upon the relative number of shares included by the Holders and
the Company.  If the Holders bear the Registration Expenses for any registration
proceeding begun pursuant to Section 1.2 or Section 1.5 and subsequently
withdrawn by the Holders registering shares therein, such registration
proceeding shall not be counted as a requested registration pursuant to Section
1.2 or Section 1.5 hereof.  All Selling Expenses relating to securities so
registered shall be borne by the Holders of such securities pro rata on the
basis of the number of shares of securities so registered on their behalf.

                                       6
<PAGE>

     1.5  Registration on Form S-3.  The Company shall use its best efforts to
          ------------------------
register or qualify for registration on Form S-3 or any comparable or successor
form or forms and, if allowable, file any requested registration on Form S-3.
It is agreed that at any time when the Company is eligible to file a
registration statement on Form S-3 (or any successor form), the Holders may
request that the Company file a registration statement pursuant to Rule 415
under the Securities Act to permit the offering of the Registrable Shares on a
delayed or continuous basis.

     1.6  Registration Procedures.  In the case of each registration effected by
          -----------------------
the Company pursuant to this Agreement, the Company will keep each Holder
advised in writing as to the initiation of each registration and as to the
completion thereof.  At its expense, the Company will use its best efforts to:

          (a)  Keep such registration effective for a period of one hundred
eighty (180) days or such longer period as may be agreed between the Company and
the Holders; provided, however, that (i) such one hundred eighty (180) day
period shall be extended for a period of time equal to the period the Holders
refrain from selling any securities included in such registration at the request
of an underwriter of Common Stock (or other securities) of the Company and any
period during which any stop order, injunction or other order or requirement of
the Commission or any other governmental agency or court interfering with the
Registration Statement is in effect; and (ii) in the case of any registration of
Registrable Shares on Form S-3 which are intended to be offered on a continuous
or delayed basis, such one hundred eighty (180) day period may be extended by
the Company as necessary to keep the registration statement effective until all
such Registrable Shares have been sold or withdrawn, provided that Rule 415, or
any successor rule under the Securities Act, permits an offering on a continuous
or delayed basis, and provided further that applicable rules under the
Securities Act governing the obligation to file a post-effective amendment
permit, in lieu of filing a post-effective amendment that (I) includes any
prospectus required by Section 10(a)(3) of the Securities Act or (II) reflects
facts or events representing a material or fundamental change in the information
set forth in the registration statement, the incorporation by reference of
information required to be included in (I) and (II) above to be contained in
periodic reports filed pursuant to Section 13 or 15(d) of the Exchange Act in
the registration statement;

          (b)  Prepare and file with the Commission such amendments and
supplements to such registration statement and the prospectus used in connection
with such registration statement as may be necessary to comply with the
provisions of the Securities Act or any applicable securities laws with respect
to the disposition of all securities covered by such registration statement
during such period in accordance with the intended method or methods of
disposition by the sellers thereof set forth in such registration statement;

          (c)  Furnish such number of copies of such registration statement and
such prospectuses (including each preliminary prospectus) and other documents
incident thereto, including any amendment of or supplement thereto, as a Holder
from time to time may reasonably request;

                                       7
<PAGE>

          (d)  As soon as practicable, notify each seller of Registrable Shares
covered by such registration statement at any time when a prospectus relating
thereto is required to be delivered under the Securities Act upon the discovery
or the happening of any event as a result of which the prospectus included in
such registration statement, as then in effect, includes an untrue statement of
a material fact or omits to state a material fact required to be stated therein
or necessary to make the statements therein not misleading or incomplete in the
light of the circumstances then existing, and at the request of any such seller,
promptly prepare and furnish to such seller a reasonable number of copies of a
supplement to or an amendment of such prospectus as may be necessary so that, as
thereafter delivered to the purchasers of such shares, such prospectus shall not
include an untrue statement of a material fact or omit to state a material fact
required to be stated therein or necessary to make the statements therein not
misleading or incomplete in the light of the circumstances then existing;

          (e)  Cause all such Registrable Shares registered pursuant hereunder
to be listed on or prior to the effective date of such registration statement on
each securities exchange or national market on which similar securities issued
by the Company are then listed or, if permitted by the rules of such securities
exchange or national market, as soon as practicable after the date of issuance;

          (f)  use all reasonable and diligent efforts to register or qualify
such Registrable Shares under such securities laws of such jurisdictions in the
United States as the Holders reasonably request and keep such registration or
qualification in effect for so long as such registration statement remains in
effect, and do any and all other acts and things which may be reasonably
necessary or advisable to enable the sellers of Registrable Shares to consummate
the disposition in such jurisdictions of such securities owned by such sellers;
provided that the Company shall not be required to consent to general service of
--------
process in any such jurisdiction unless the Company is already subject to
service in such jurisdiction and except as may be required by the Securities
Act;

          (g)  enter into such agreements (including underwriting agreements) as
the underwriters or their counsel reasonably request in order to expedite or
facilitate the disposition of such Registrable Shares and, to the extent
reasonably requested by the managing underwriters of any underwritten offering,
send appropriate officers of the Company to attend "road shows" scheduled in
connection with any such registration; provided that the Company shall not be
required to find an underwriter for any registration in which it is not selling
securities;

          (h)  make available for inspection by the Holders or their counsel,
such financial and other records, or corporate documents of the Company, as
shall be necessary, in the opinion of their respective counsel, to conduct a
reasonable investigation within the meaning of the Securities Act, and give the
Holders and their attorneys the opportunity to participate in the preparation of
such registration statement, each prospectus included therein or each prospectus
filed with the Commission in connection therewith;

                                       8
<PAGE>

          (i)  promptly notify each seller of Registrable Shares and each
underwriter, if any:

               (i)   when such registration statement or any prospectus used in
connection therewith has been filed and, with respect to such registration
statement or any post-effective amendment thereto, when the same has become
effective;

               (ii)  of any written comments from the Commission with respect to
any filing referred to in clause (i) and of any written request by the
Commission for amendments or supplements to such registration statement or
prospectus;

               (iii) of the notification to the Company by the Commission or any
other regulatory authority of its initiation of any proceeding with respect to,
or of the issuance by the Commission or any other regulatory authority of, any
stop order suspending the effectiveness of such registration statement; and

               (iv)  of the receipt by the Company of any notification with
respect to the suspension of the qualification of any Registrable Shares for
sale under the applicable securities or blue sky laws of any jurisdiction;

and, in the case of clauses (ii), (iii) and (iv), promptly use all reasonable
and diligent efforts (A) to respond satisfactorily to any such comments and to
file promptly any necessary amendments or supplements; (B) to prevent the
issuance of any stop order or to obtain its withdrawal if such stop order should
be issued; and (C) to obtain the withdrawal of any such suspension of
qualification, respectively;

          (j)  furnish to each seller of Registrable Shares (if the same has
been delivered to the underwriter) a singed counterpart, addressed to such
seller; of:

          (i)  an opinion of counsel to the Company, dated the effective date of
such registration statement (and, if such registration includes an underwritten
public offering, dated the date of the closing under the underwriting
agreement), reasonably satisfactory in form and substance to such seller (and
such underwriter); and

          (ii) a "comfort" letter, dated the effective date of such registration
statement (and, if such registration includes an underwritten public offering,
dated the date of the closing under the underwriting agreement), signed by the
independent public accountants who have certified the Company's financial
statements included in such Registration Statement, provided that such seller of
Registrable Shares provides such accountants with such certificates as are
reasonably and customarily requested by such accountants;

in each case covering substantially the same matters with respect to such
registration statement (and the prospectus included therein) and, in the case of
the accountants' letter, with respect to events subsequent to the date of such
financial statements and other financial matters, as are

                                       9
<PAGE>

customarily covered in opinions of issuer's counsel and in accountants' letters
delivered to the underwriters in underwritten public offerings of securities;

          (k)  otherwise use all reasonable and diligent efforts to comply with
all applicable securities laws and make available to its security holders, as
soon as reasonably practicable an earning statement satisfying the provisions of
Section 1.1(a) of the Securities Act and Rule 158 promulgated thereunder; and

          (l)  cooperate with the Holders and each underwriter or agent
participating in the disposition of such Registrable Shares and their respective
counsel in connection with any filings required to be made with the National
Association of Securities Dealers, Inc.

     1.7  Indemnification.
          ---------------

          (a)  The Company will indemnify and hold harmless each Indemnified
Party with respect to which registration, qualification, or compliance has been
effected pursuant to this Agreement, against all expenses, claims, penalties,
judgments, costs, suits, losses, damages, and liabilities (or actions,
proceedings, or settlements in respect thereof) arising out of, relating to, as
a result of or based on any untrue statement (or alleged untrue statement) of a
material fact contained in any prospectus, offering circular, or other document
(including any related registration statement, notification, or the like)
incident to any such registration, qualification, or compliance, or any omission
(or alleged omission) to state therein a material fact required to be stated
therein or necessary to make the statements therein not misleading, or any
violation by the Company of the Securities Act or any rule or regulation
thereunder applicable to the Company and relating to action or inaction required
of the Company in connection with any such registration, qualification, or
compliance, and will reimburse each such Indemnified Party, each such
underwriter, and each person who controls any such underwriter, for any legal
and any other expenses reasonably incurred in connection with investigating and
defending or settling any such claim, loss, damage, liability, or action,
provided that the Company will not be liable in any such case to the extent that
any such claim, loss, damage, liability, or expense arises out of or is based on
any untrue statement or omission based upon written information furnished to the
Company by such Holder or underwriter and stated to be specifically for use
therein. It is agreed that the indemnity agreement contained in this Section
1.7(a) shall not apply to amounts paid in settlement of any such loss, claim,
damage, liability, or action if such settlement is effected without the consent
of the Company (which consent has not been unreasonably withheld).

          (b)  Each Holder severally, but not jointly, will, if Registrable
Shares held by him are included in the securities as to which such registration,
qualification, or compliance is being effected, indemnify the Company, each of
its directors, officers, partners, each person who controls the Company within
the meaning of Section 15 of the Securities Act, each other such Holder and
Other Stockholder, and each of their officers, directors, and partners, and each
person controlling such other Holder or Other Stockholder, against all claims,
losses, damages and liabilities (or actions in respect thereof) arising out of
or based on any untrue statement (or alleged untrue statement) of a material
fact contained in any such registration statement,

                                       10
<PAGE>

prospectus, offering circular, or other document, or any omission (or alleged
omission) to state therein a material fact required to be stated therein or
necessary to make the statements therein not misleading, and will reimburse the
Company and such other Holders, Other Stockholders, directors, officers,
partners, persons, underwriters, or control persons for any legal or any other
expenses reasonably incurred in connection with investigating or defending any
such claim, loss, damage, liability, or action, in each case to the extent, but
only to the extent, such untrue statement (or alleged untrue statement) or
omission (or alleged omission) is made in such registration statement,
prospectus, offering circular, or other document in reliance upon and in
conformity with written information furnished to the Company by such Holder and
stated to be specifically for use therein; provided, however, that the
obligations of such Holder hereunder shall not apply to amounts paid in
settlement of any such claims, losses, damages, or liabilities (or actions in
respect thereof) if such settlement is effected without the consent of such
Holder (which consent shall not be unreasonably withheld); and provided further
that in no event shall any indemnity under this Section 1.7(b) exceed the lesser
of (A) the net proceeds from the offering received by such Holder or (B) that
proportion of aggregate losses, claims, damages, liabilities or expenses
indemnified against by such Holder as determined by the proportion of the shares
sold by such Holder compared to the total number of Shares sold.

          (c)  Each party entitled to indemnification under this Section 1.7
(the "Indemnified Party") shall give notice to the party required to provide
indemnification (the "Indemnifying Party") promptly after such Indemnified Party
has actual knowledge of any claim as to which indemnity may be sought, and shall
permit the Indemnifying Party to assume the defense of any such claim or any
litigation resulting therefrom, provided that counsel for the Indemnifying Party
who shall conduct the defense of such claim or any litigation resulting
therefrom, shall be approved by the Indemnified Party (whose approval shall not
unreasonably be withheld), and the Indemnified Party may participate in such
defense at such party's expense; provided, however, that an Indemnified Party
(together with all other indemnified parties which may be represented without
conflict by one counsel) shall have the right to retain one separate counsel
with the fees and expenses to be paid by the Indemnifying Party, if
representation of such Indemnified Party would be inappropriate due to actual or
potential differing interests between such Indemnified Party and any other party
represented by such counsel in such proceeding; and provided further that the
failure of any Indemnified Party to give notice as provided herein shall not
relieve the Indemnifying Party of its obligations under this Agreement, to the
extent such failure is not prejudicial. No Indemnifying Party, in the defense of
any such claim or litigation, shall, except with the consent of each Indemnified
Party, consent to entry of any judgment or enter into any settlement that does
not include as an unconditional term thereof the giving by the claimant or
plaintiff to such Indemnified Party of a release from all liability in respect
to such claim or litigation. Each Indemnified Party shall furnish such
information regarding itself or the claim in question as an Indemnifying Party
may reasonably request in writing and as shall be reasonably required in
connection with defense of such claim and litigation resulting therefrom.

          (d)  If the indemnification provided for in this Section 1.7 is held
by a court of competent jurisdiction to be unavailable to an Indemnified Party
with respect to any loss,

                                       11
<PAGE>

liability, claim, damage, or expense referred to therein, then the Indemnifying
Party, in lieu of indemnifying such Indemnified Party hereunder, shall
contribute to the amount paid or payable by such Indemnified Party as a result
of such loss, liability, claim, damage, or expense in such proportion as is
appropriate to reflect (i) the relative benefit received by the parties; and
(ii) the relative fault of the Indemnifying Party on the one hand and of the
Indemnified Party on the other in connection with the statements or omissions
that resulted in such loss, liability, claim, damage, or expense as well as any
other relevant equitable considerations. The relative benefits received by the
Company on one hand and the Holders on the other hand shall be deemed to be in
the same respective proportions as the net proceeds from the offering of any
securities registered thereunder, the shares of the Common Stock (before
deducting expenses) received by the Company, and the net proceeds from the
offering of any shares of Common Stock (before deducting expenses) received by
the Holders bear to the aggregate public offering price of the securities
registered thereunder. The relative fault of the Indemnifying Party and of the
Indemnified Party shall be determined by reference to, among other things,
whether the untrue or alleged untrue statement of a material fact or the
omission to state a material fact relates to information supplied by the
Indemnifying Party or by the Indemnified Party and the parties' relative intent,
knowledge, access to information, and opportunity to correct or prevent such
statement or omission.

     1.8  Information by Holder.  Each Holder of Registrable Shares shall
          ---------------------
furnish to the Company such information regarding such Holder and the
distribution proposed by such Holder as the Company may reasonably request in
writing and as shall be reasonably required in connection with any registration,
qualification, or compliance referred to in this Agreement.

     1.9  Rule 144 Reporting.  With a view to making available the benefits of
          ------------------
certain rules and regulations of the Commission that may permit the sale of the
Restricted Securities (as defined in Rule 144 under the Securities Act) to the
public without registration, the Company agrees to use its best efforts to:
          (a)  Make and keep public information regarding the Company available
as those terms are understood and defined in Rule 144 under the Securities Act,
at all times;

          (b)  File with the Commission in a timely manner all reports and other
documents required of the Company under the Securities Act and the Exchange Act
at any time after it has become subject to such reporting requirements;

          (c)  So long as a Holder owns any Restricted Securities, furnish to
the Holder forthwith upon written request a written statement by the Company as
to its compliance with the reporting requirements of Rule 144, and of the
Securities Act and the Exchange Act (at any time after it has become subject to
such reporting requirements), a copy of the most recent annual or quarterly
report of the Company, and such other reports and documents so filed as a Holder
may reasonably request in availing itself of any rule or regulation of the
Commission allowing a Holder to sell any such securities without registration.

     1.10 Transfer or Assignment of Registration Rights.  Except by operation
          ---------------------------------------------
of law,

                                       12
<PAGE>

the rights to cause the Company to register securities granted to a Holder by
the Company under this Agreement may not be transferred or assigned to a
transferee or assignee of any shares of Registrable Shares, without the consent
of the Company, provided that each Holder may assign its rights under Section
1.7 to an affiliate to which such Holder may transfer its ownership of all or
any of its Common Stock of the Company without such prior written consent. The
Company is to be given written notice prior to any proposed transfer, stating
the name and address of the transferee or assignee and identifying the
securities with respect to which such registration rights are being transferred
or assigned; provided further, that the transferee or assignee of any rights
must assume the obligations of such Holder under this Agreement.

     1.11  "Market Stand-Off" Agreement.  If requested by the Company and an
           ----------------------------
underwriter of Common Stock (or other securities) of the Company, to the extent
that the Holders have a seat on the Company's board of directors or own more
than five percent (5%) of the Common Stock of the Company, each Holder shall
enter into a lockup agreement with the underwriter or underwriters of such
underwritten offering containing provisions of the type customarily employed in
such agreements with respect to registered public offerings by nationally-
recognized underwriting firms for a period not to exceed 180 days, provided that
all officers and directors of the Company enter into similar agreements.

     The obligations described in this Section 1.11 shall not apply to a
registration relating solely to employee benefit plans on Form S-8 or a similar
form that may be promulgated in the future, or a registration relating solely to
a Commission Rule 145 transaction on Form S-4 or similar forms that may be
promulgated in the future.  The Company may impose stop-transfer instructions
with respect to the shares (or securities) subject to the foregoing restriction
until the end of said one hundred eighty (180) day period.

                                       13
<PAGE>

     1.12  Allocation of Registration Opportunities.
           ----------------------------------------

           (a)   Allocation.  In any circumstance in which all of the
Registrable Shares and other shares of Common Stock of the Company with
registration rights (the "Other Shares") requested to be included in a
registration on behalf of the Holders or other selling stockholders cannot be so
included as a result of limitations of the aggregate number of shares of
Registrable Shares and Other Shares that may be so included, the number of
shares of Registrable Shares and Other Shares that may be so included shall be
allocated among the Holders and other selling stockholders requesting inclusion
of shares on the basis of the ratio set forth in this Section 1.12. If any
Holder or other selling stockholder does not request inclusion of the maximum
number of shares of Registrable Shares and Other Shares allocated to him
pursuant to the above-described procedure, the remaining portion of his
allocation shall be reallocated among those requesting Holders and other selling
stockholders whose allocations did not satisfy their requests pro rata on the
basis of the number of shares of Registrable Shares and Other Shares which would
be held by such Holders and other selling stockholders, and this procedure shall
be repeated until all of the shares of Registrable Shares and Other Shares which
may be included in the registration on behalf of the Holders and other selling
stockholders have been so allocated.

           (b)   Ratio.  In the event that there is any allocation of shares as
specified in this Agreement, each Holder of Registrable Shares who has requested
registration will be able to include at its option in such registration up to
the percentage of such Holder's amount of Registrable Shares compared with  the
total Registrable Shares  owned by all Holders.

     1.13  Delay of Registration.  No Holder shall have any right to take any
           ---------------------
action to restrain, enjoin, or otherwise delay any registration as the result of
any controversy that might arise with respect to the interpretation or
implementation of this Section 1.

     1.14  Termination of Registration Rights.  The right of any Holder to
           ----------------------------------
inclusion in any registration pursuant to Section 1.2, 1.3 and 1.5 shall
terminate on the date all Registrable Shares may immediately be sold by such
Holder under Rule 144 during any 90-day period.  Section 1.7 will survive the
expiration of this Agreement and continue, thereafter, in full force and effect.

     1.15  No Sales Prior to One Year from Closing.   Notwithstanding any other
           ---------------------------------------
provision of this agreement, the Holders hereby agreed that they will not make
any sales of any securities of the Company for a period of one year from the
date of Closing, except that the Holders may transfer the Registrable Shares to
French Subsidiary and U.S. Subsidiary.

     1.16  No Registration Rights in Connection with PIPE Offerings.
           --------------------------------------------------------
Notwithstanding any other provision of this agreement, the Holders shall have no
registration rights with respect to a registration statement covering the resale
of securities sold by the Company in a private placement of at least $5.0
million in securities, if a condition of the private placement is that the
Company file a registration statement allowing resale of the securities within a
period of 90 days after the private placement.  The Company may, in connection
with any such private placement, request the Holders to include their shares in
the private sale if in the reasonable judgment of the

                                       14
<PAGE>

Company the inclusion such shares would increase the likelihood of successfully
completing the private offering, but the Holders shall be under no obligation to
include their shares in the private offering.

     1.17  Holders Subject to Black-out Periods While Representative Sits on
           -----------------------------------------------------------------
Board.  Each Holder agrees that as long as such Holder has a member
-----
representative on the board of directors vote of the Company, then the Holder is
subject to the same "black-out" periods as the director with respect to
purchases and sales of Company securities, as set forth in the Company insider
trading policy, as the same may be amended from time to time.

     1.18  Company Determination with Respect to Financing.    If, at any time
           -------------------------------------------------
during which the Company has a registration statement in effect for the Holders,
and the Company determines that its financial position is such that it is
required to conduct a financing and the Company shall furnish to such Holders a
certificate signed by the President of the Company stating in the good faith
judgment of the Board of Directors of the Company, its financial position is
such that it is required to conduct a financing, the Company may, at its option
on five (5) days written notice to the Holders, either (i) deregister the shares
under the registration statement or (ii) require that the Holders cease selling
under the after registration statement until conclusion of the Company
financing.   Upon such event, if the shares are withdrawn from registration,
then the Holder will be entitled to one additional demand rights and if sales
are suspended under the registration statement, the Company shall keep the
registration statement in effect for a period of time equal to the period during
which sales could not be made.

                                   ARTICLE 2
                                 MISCELLANEOUS
                                 -------------

     2.1   Amendment; Waiver.  No waiver and no modification or amendment of any
           -----------------
provision of this Agreement shall be effective unless specifically made in
writing and duly signed by the parties to be bound thereby.  Waiver by a party
of any breach of or failure to comply with any of the provisions of this
Agreement by any other party shall not be construed as, or constitute, a
continuing waiver of, or a waiver of any other breach of, or failure to comply
with, any other provision of this Agreement.

     2.2   Governing Law.  This Agreement shall be governed by and construed in
           -------------
accordance with the laws of the State of Minnesota applicable to contracts made
and to be performed therein without regard to the principles of any jurisdiction
with respect to conflicts of laws.

                                       15
<PAGE>

     2.3   Disputes.
           --------

          (a)  Any dispute between Urologix and EDAP arising out of or in
connection with this Agreement (or any agreements or documents delivered by the
parties hereto pursuant to the terms of this Agreement) or any alleged breach
hereof may, at the option of either Urologix or EDAP, be submitted for
discussion and possible resolution by senior officers of Urologix and EDAP, as
designated by their respective chief executive officers.

          (b)  All disputes arising, relating to or arising in connection with
this Agreement, including those pertaining to the validity, interpretation,
construction or breach hereof or of any legal obligation owed or claimed to be
owed by any party hereto to any other party hereto or its Affiliates, that is
not otherwise amicably settled between the parties shall exclusively be resolved
by arbitration between EDAP and Urologix pursuant to the Commercial Arbitration
Rules of the American Arbitration Association (the "Rules"), with the
arbitration to be conducted in the English language and taking place in New
York, New York.

          (c)  The arbitral tribunal shall be composed of three arbitrators
appointed in accordance with the Rules. The Chairman of the arbitral tribunal
shall be nominated by the two arbitrators nominated respectively by EDAP and
Urologix, and if they fail to agree upon such Chairman within 30 days after the
second arbitrator has been appointed, such Chairman shall be appointed by the
American Arbitration Association. No arbitrator shall be or have been a present
or past employee, officer, director, legal counsel, consultant or agent of
either party or its Affiliates. All arbitrators shall be of legal education,
unless the parties agree otherwise at the time. Unless prohibited or restricted
by applicable law, each party agrees to provide to the arbitrators and the other
party, subject to a strict confidentiality agreement, such documents, other
evidence, witness testimony as may reasonably be requested by the other party
and as are relevant to the issues being arbitrated. The arbitrators may restrict
or terminate discovery requests which they conclude are unreasonable, unduly
burdensome or not relevant to the issues being arbitrated. Such discovery shall
occur during a reasonable time period. The arbitrators shall not have the power
to act as "amiable compositeurs" with respect to any dispute submitted to such
arbitration, but rather shall make their decision based on their understanding
and interpretation of the applicable law and facts. The fees and disbursements
of the arbitrators shall be allocated between the disputing party and the other
party to the dispute in the same proportion that the disputed items so submitted
to the arbitrators that are unsuccessfully disputed by each (as finally
determined by the arbitrators) bears to the total amount of all disputed items
so submitted. Notwithstanding any provision of this Agreement to the contrary,
(i) any party shall be entitled to seek a judicial order for interim relief to
the extent necessary to safeguard the property that is the subject matter of an
arbitration proceeding hereunder, and (ii) judgment upon the award rendered in
any arbitration proceeding hereunder may be entered in any court having
jurisdiction or application may be made to such court in a judicial acceptance
of the award and an order by enforcement, as the case may be. The parties hereto
agree that the arbitrators appointed pursuant to this Section 2.3 shall have the
power to grant equitable relief, including temporary and permanent injunctive
relief and specific performance.

     (d) Notwithstanding any other provision in this Section 2.3 to the
contrary,

                                       16
<PAGE>

either party may bring court proceedings or claims against the other as part of
separate litigation commenced by an unrelated third party.

     2.4   Severability.  Whenever possible, each provision of this Agreement
           ------------
will be interpreted in such manner as to be effective and valid under the
applicable law, but if any provision of this Agreement is held to be prohibited
by or invalid under applicable law, such provision will be ineffective only to
the extent of such prohibition or invalidity, without invalidating the remainder
of such provision or the remaining provisions of this Agreement.

     2.5   Counterparts.  This Agreement may be executed in one or more
           ------------
counterparts, all of which taken together will constitute one and the same
instrument.

     2.6   Interpretation.  This Agreement has been fully negotiated by the
           --------------
parties through their legal counsel.  Accordingly, in interpreting this
Agreement, the rule of the interpretation requiring that documents be construed
against the draftsman shall be inapplicable.

     2.7   Notices.  All notices, requests and other communications to any party
           -------
hereunder shall be in writing, will be effective upon receipt, and shall be
given or made (and shall be deemed to have been duly given or made upon receipt)
by delivery in person, by courier service, by cable, by facsimile transmission,
by telegram or by registered or certified mail (postage prepaid, return receipt
requested) to the respective parties at the following addresses (or at such
other address for a party as shall be specified in a notice given in accordance
with this Section 2.8)

     if to EDAP or French Subsidiary and U.S. Subsidiary, to:

                                       EDAP TMS S.A.
                                       4-6 rue du Dauphine
                                       69120 Vaulx-en-Velin
                                       France
                                       Attention: Chief Executive Officer

     with a copy to:                   Cleary, Gottlieb, Steen & Hamilton
                                       City Place House
                                       55 Basinghall Street
                                       London EC2V 5EH, England
                                       Attention: Pierre-Marie Boury

     if to Urologix to:                Urologix, Inc.
                                       14405 Twenty-First Avenue North
                                       Minneapolis, Minnesota 55447
                                       Attention: Michael M. Selzer, Jr.

                                       17
<PAGE>

     with a copy to:                   Lindquist & Vennum P.L.L.P.
                                       4200 IDS Center
                                       80 South 8TH Street
                                       Minneapolis, MN 55402
                                       Attention:  Ronald G. Vantine

     2.8  No Third Party Beneficiary.  The provisions of this Agreement are for
          --------------------------
the sole benefit of the parties to this Agreement and are not for the benefit of
any third party.

     2.9  English Language.  This Agreement shall be executed solely in English
          ----------------
language which shall be controlling in all respects whether or not translations
are made of this Agreement into any other language.

     IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of
the date first written above.

                                       UROLOGIX, INC.

                                       ___________________________________
                                       By: Michael M. Selzer, Jr.
                                       Its: Chief Executive Officer

                                       EDAP TMS S.A.

                                       ___________________________________
                                       By: Eric Simon
                                       Its: Chief Executive Officer

                                       TECHNOMED MEDICAL SYSTEMS S.A.

                                       ___________________________________
                                       By: Eric Simon
                                       Its: Chief Executive Officer

                                       EDAP TECHNOMED INC.

                                       ___________________________________
                                       By: Antoine Tetard
                                       Its: President

                                       18<PAGE>

                                                                    EXHIBIT 10.3

                            RESTRICTION ON TRANSFER

     The securities evidenced hereby may not be transferred without (i) the
opinion of counsel satisfactory to the Company that such transfer may be
lawfully made without registration under the Federal Securities Act of 1933 and
all applicable state securities laws or (ii) such registration.

                                    WARRANT

                 To Subscribe for and Purchase Common Stock of

                                Urologix, Inc.
W-1
---

     THIS CERTIFIES THAT, for value received, EDAP TMS S.A., a French
corporation, or its registered assigns, is entitled to subscribe for and
purchase from Urologix, Inc. (herein called the "Company"), a corporation
organized and existing under the laws of the State of Minnesota, at the price
specified below (subject to adjustment as noted below) at any time from and
after the date hereof to and including October 1, 2005, Three Hundred Twenty-
seven Thousand Four Hundred Sixty-six (327,466) fully paid and nonassessable
shares of the Company's Common Stock, $.01 par value (subject to adjustment as
noted below).

     The Warrant purchase price (subject to adjustment as noted below) shall be
$7.725 per share.

     This Warrant is subject to the following provisions, terms and conditions:

     1.  Right to Exercise.  The rights represented by this Warrant may be
         -----------------
exercised by the holder hereof, in whole or in part, by written notice of
exercise delivered to the Company three (3) business days prior to the intended
date of exercise and by the surrender of this Warrant (properly endorsed if
required) at the principal office of the Company and upon payment to it by check
of the purchase price for such shares (the "Warrant Shares").  The Company
agrees that the Warrant Shares so purchased shall be and are deemed to be issued
to the holder hereof as the record owner of such Warrant Shares as of the close
of business on the date on which this Warrant shall have been surrendered and
payment made for such Warrant Shares as aforesaid.  Subject to the provisions of
the next succeeding paragraph, certificates for the Warrant Shares so purchased
shall be delivered to the holder hereof within a reasonable time, not exceeding
five (5) business days, after the rights represented by this Warrant shall have
been so exercised, and, unless this Warrant has expired, a new Warrant
representing the number of shares, if any, with respect to which this Warrant
shall not then have been exercised shall also be delivered to the holder hereof
within such time.

     2.  Obligations Subject to Restrictions on Transfer.  Notwithstanding the
         -----------------------------------------------
foregoing, however, the Company shall not be required to deliver any certificate
for shares of stock upon exercise of this Warrant except in accordance with the
provisions, and subject to the limitations,

                                       1
<PAGE>

of paragraph 7 hereof and the restrictive legend under the heading "Restriction
on Transfer" below.

     3.  Authorization of Shares.  The Company covenants and agrees that all
         -----------------------
Warrant Shares that may be issued upon the exercise of the rights represented by
this Warrant will, upon issuance, be duly authorized and issued, fully paid and
nonassessable.  The Company further covenants and agrees that during the period
within which the rights represented by this Warrant may be exercised, the
Company will at all times have authorized, and reserved for the purpose of issue
or transfer upon exercise of the subscription rights evidenced by this Warrant,
a sufficient number of shares of its Common Stock to provide for the exercise of
the rights represented by this Warrant.

     4.  Antidilution Provisions.  The above provisions are, however, subject to
         -----------------------
the following:

     (a) The warrant purchase price shall, from and after the date of issuance
of this Warrant, be subject to adjustment from time to time as hereinafter
provided.  Upon each adjustment of the warrant purchase price, the holder of
this Warrant shall thereafter be entitled to purchase, at the warrant purchase
price resulting from such adjustment, the number of Warrant Shares obtained by
multiplying the warrant purchase price in effect immediately prior to such
adjustment by the number of Warrant Shares purchasable pursuant hereto
immediately prior to such adjustment and dividing the product thereof by the
warrant purchase price resulting from such adjustment.

     (b) In case the Company shall at any time subdivide its outstanding shares
of Common Stock into a greater number of shares, the warrant purchase price in
effect immediately prior to such subdivision shall be proportionately reduced,
and conversely, in case the outstanding shares of Common Stock of the Company
shall be combined into a smaller number of shares, the warrant purchase price in
effect immediately prior to such combination shall be proportionately increased.

     (c) If any event occurs as to which in the opinion of the Board of
Directors of the Company the other provisions of this paragraph 4 are not
strictly applicable or if strictly applicable would not fairly protect the
purchase rights of the holder of this Warrant or of Common Stock in accordance
with the essential intent and principles of such provisions, then the Board of
Directors shall make an adjustment in the application of such provisions, in
accordance with such essential intent and principles, so as to protect such
purchase rights as aforesaid.

     5.  No Voting Rights.  This Warrant shall not entitle the holder hereof to
         ----------------
any voting rights or other rights as a stockholder of the Company.

     6.  Notice Prior to Transfer.  The holder of this Warrant, by acceptance
         ------------------------
hereof, agrees

                                       2
<PAGE>

to give written notice to the Company before transferring this Warrant or the
Warrant Shares of such holder's intention to do so, describing briefly the
manner of any proposed transfer of this Warrant or such holder's intention as to
the disposition to be made of Warrant Shares. Such holder shall also provide the
Company with an opinion of counsel satisfactory to the Company to the effect
that the proposed transfer of this Warrant or disposition of Warrant Shares may
be effected without registration or qualification (under any Federal or State
law) of this Warrant or Warrant Shares. Upon receipt of such written notice and
opinion by the Company, such holder shall be entitled to transfer this Warrant,
or to exercise this Warrant in accordance with its terms and dispose of the
Warrant Shares received upon such exercise or to dispose of Warrant Shares
received upon the previous exercise of this Warrant, all in accordance with the
terms of the notice delivered by such holder to the Company, provided that an
appropriate legend respecting the aforesaid restrictions on transfer and
disposition may be endorsed on this Warrant or the certificates for such Warrant
Shares.

     7.  Transferability.  Subject to the provisions of paragraph 6 hereof, this
         ---------------
Warrant and all rights hereunder are transferable, in whole or in part, at the
principal office of the Company by the holder hereof in person or by duly
authorized attorney, upon surrender of this Warrant properly endorsed.  Each
taker and holder of this Warrant, by taking or holding the same, consents and
agrees that the bearer of this Warrant, when endorsed, may be treated by the
Company and all other persons dealing with this Warrant as the absolute owner
hereof for any purpose and as the person entitled to exercise the rights
represented by this Warrant, or to the transfer hereof on the books of the
Company, any notice to the contrary notwithstanding; but until such transfer on
such books, the Company may treat the registered holder hereof as the owner for
all purposes.

     8.  Ability to Exchange Warrants.  This Warrant is exchangeable, upon the
         ----------------------------
surrender hereof by the holder hereof at the principal office of the Company,
for new Warrants of like tenor representing in the aggregate the right to
subscribe for and purchase the number of Warrant Shares which may be subscribed
for and purchased hereunder, each of such new Warrants to represent the right to
subscribe for and purchase such number of Warrant Shares as shall be designated
by said holder hereof at the time of such surrender.

     9.  Registration Rights.  All Warrant Shares shall have the registration
         -------------------
rights set forth in the Registration Rights Agreement dated as of this date
between Urologix, Inc and EDAP TMS S.A, Technomed Medical Systems S.A. and EDAP
Technomed, Inc.

                                       3
<PAGE>

     10.  Governance.  All questions concerning this Warrant will be governed
          ----------
and interpreted and enforced in accordance with the internal law of the State of
Minnesota..

     IN WITNESS WHEREOF, the Company has caused this Warrant to be signed by its
duly authorized officer and this Warrant to be dated as of October 1,  2000.

                                             Urologix, Inc.

                                             By.................................

                                               Its..............................

                                       4
<PAGE>

FORM OF ASSIGNMENT
                      (To Be Signed Only Upon Assignment)

  FOR VALUE RECEIVED, the undersigned hereby sells, assigns and transfers unto

this Warrant, and appoints

to transfer this Warrant on the books of the Company with the full power of
substitution in the premises.

Dated:

In the presence of:

                                    ____________________________________________
                                    (Signature must conform in all respects to
                                    the name of the holder as specified on the
                                    face of this Warrant without alteration,
                                    enlargement or any change whatsoever, and
                                    the signature must be guaranteed in the
                                    usual manner)

                                       5
<PAGE>

SUBSCRIPTION FORM

          To be Executed by the Holder of this Warrant if such Holder
             Desires to Exercise this Warrant in Whole or in Part:

To:   Urologix, Inc.  (the "Company")

       The undersigned _________________________

                    Please insert Social Security or other
                       identifying number of Subscriber:
                           _________________________

hereby irrevocably elects to exercise the right of purchase represented by this
Warrant for, and to purchase thereunder, ________ shares of the Common Stock
provided for therein and tenders payment herewith to the order of the Company in
the amount of $_______, such payment being made as provided on the face of this
Warrant.

       The undersigned requests that certificates for such shares of Common
Stock be issued as follows:

Name:       ____________________________________________________________________

Address:    ____________________________________________________________________

Deliver to: ____________________________________________________________________

Address:    ____________________________________________________________________

and, if such number of shares of Common Stock shall not be all the shares of
Common Stock purchasable hereunder, that a new Warrant for the balance remaining
of the shares of Common Stock purchasable under this Warrant be registered in
the name of, and delivered to, the undersigned at the address stated above.

Dated:
                                 Signature _____________________________________
                                       Note:  The signature on this Subscription
                                       Form must correspond with the name as
                                       written upon the face of this Warrant in
                                       every particular, without alteration or
                                       enlargement or any change whatever.

                                       6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00016-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00016-of-00352.parquet"}]]